MX2019007301A - Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida. - Google Patents
Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida.Info
- Publication number
- MX2019007301A MX2019007301A MX2019007301A MX2019007301A MX2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A MX 2019007301 A MX2019007301 A MX 2019007301A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- pharmaceutical compounds
- making substituted
- substituted porphyrin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000004032 porphyrins Chemical class 0.000 title abstract 2
- XOGDUYVYKGKZAC-UHFFFAOYSA-N 23-(2-butoxyethyl)-12-pyridin-2-yl-21H-porphyrin Chemical compound C1=CC(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=NC1=CC=1N(CCOCCCC)C4=CC=1C1=CC=CC=N1 XOGDUYVYKGKZAC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- MMIPFLVOWGHZQD-UHFFFAOYSA-N manganese(3+) Chemical compound [Mn+3] MMIPFLVOWGHZQD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B47/00—Formation or introduction of functional groups not provided for in groups C07B39/00 - C07B45/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662436743P | 2016-12-20 | 2016-12-20 | |
| PCT/US2017/067263 WO2018118891A1 (en) | 2016-12-20 | 2017-12-19 | Methods of making substituted porphyrin pharmaceutical compounds and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019007301A true MX2019007301A (es) | 2019-10-30 |
Family
ID=62628012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019007301A MX2019007301A (es) | 2016-12-20 | 2017-12-19 | Metodos para elaborar composiciones y compuestos farmaceuticos de porfirina sustituida. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190330220A1 (enExample) |
| EP (1) | EP3558902A4 (enExample) |
| JP (1) | JP2020502280A (enExample) |
| KR (1) | KR20190098211A (enExample) |
| CN (1) | CN110291060A (enExample) |
| CA (1) | CA3046357A1 (enExample) |
| MX (1) | MX2019007301A (enExample) |
| WO (1) | WO2018118891A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190130654A (ko) * | 2017-04-04 | 2019-11-22 | 바이오미매틱스 제이브이, 엘엘씨 | 방사선 요법 및/또는 화학요법 노출과 연관된 부작용의 치료 및/또는 예방을 위한 방법, 조성물, 및 키트 |
| US11344574B2 (en) | 2017-09-29 | 2022-05-31 | Duke University | Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| MXPA01007451A (es) * | 1999-01-25 | 2004-03-10 | Nat Jewish Med & Res Center | Porfirinas sustituidas. |
| AU2003237500A1 (en) * | 2002-06-07 | 2003-12-22 | Duke University | Substituted porphyrins |
| WO2005077269A1 (en) * | 2004-02-09 | 2005-08-25 | Duke University | Substituted porphyrins |
| US20110275606A1 (en) * | 2009-01-07 | 2011-11-10 | Duke University | Substituted porphyrins |
| US20120065181A1 (en) * | 2009-05-26 | 2012-03-15 | Warner David S | Method of providing neuroprotection using substituted porphyrins |
| US10080759B2 (en) * | 2014-01-22 | 2018-09-25 | Duke University | Methods of treating pruritus |
-
2017
- 2017-12-19 JP JP2019554488A patent/JP2020502280A/ja active Pending
- 2017-12-19 US US16/468,911 patent/US20190330220A1/en not_active Abandoned
- 2017-12-19 MX MX2019007301A patent/MX2019007301A/es unknown
- 2017-12-19 CN CN201780086851.4A patent/CN110291060A/zh active Pending
- 2017-12-19 KR KR1020197021201A patent/KR20190098211A/ko not_active Ceased
- 2017-12-19 EP EP17882736.6A patent/EP3558902A4/en not_active Withdrawn
- 2017-12-19 CA CA3046357A patent/CA3046357A1/en not_active Abandoned
- 2017-12-19 WO PCT/US2017/067263 patent/WO2018118891A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3558902A4 (en) | 2020-06-24 |
| EP3558902A1 (en) | 2019-10-30 |
| US20190330220A1 (en) | 2019-10-31 |
| WO2018118891A1 (en) | 2018-06-28 |
| CN110291060A (zh) | 2019-09-27 |
| JP2020502280A (ja) | 2020-01-23 |
| CA3046357A1 (en) | 2018-06-28 |
| KR20190098211A (ko) | 2019-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR125320A2 (es) | Compuesto cristalino, método de preparación y composición que lo comprende | |
| MX2021002978A (es) | Lactamas biciclicas y metodos de uso de las mismas. | |
| MY196413A (en) | Substituted Carbonucleoside Derivatives Useful as Anticancer Agents | |
| EA201990495A1 (ru) | Биарильные соединения, применимые в качестве иммуномодуляторов | |
| EA201591497A1 (ru) | Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина | |
| PH12021553018A1 (en) | New egfr inhibitors | |
| MY180688A (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| SG10201811384TA (en) | Mnk inhibitors and methods related thereto | |
| EA201890522A1 (ru) | Способ получения противогрибковых соединений | |
| WO2008112939A3 (en) | Composition and method for making oligo-benzamide compounds | |
| WO2012101011A3 (en) | New aryl-benzocycloalkyl amide derivatives | |
| MY148253A (en) | Azaadamantane derivatives and methods of use | |
| MY198276A (en) | Pyrimidinyloxy Benzene Derivatives as Herbicides | |
| MX2020006612A (es) | Compuesto que funciona como inhibidor de proteína de bromodominio y composición. | |
| EA201792433A1 (ru) | Производные 2-(фенилокси- или фенилтио)пиримидина в качестве гербицидов | |
| CL2020001589A1 (es) | Proceso para la preparación de derivados de quinolina. | |
| MX394835B (es) | Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol. | |
| WO2011132051A3 (en) | Tricycle compounds as phosphodiesterase-10 inhibitors | |
| MX346980B (es) | Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona. | |
| MX2020002449A (es) | Nuevos compuestos heterociclicos fungicidas. | |
| PH12019500370A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| WO2017064627A3 (en) | Process for preparation of eribulin and intermediates thereof | |
| PH12019500822A1 (en) | Crystalline forms of eravacycline | |
| MX2019004293A (es) | Derivados de fenilamina sustituidos en la posicion 4 y uso de los mismos para proteger los cultivos combatiendo los microorganismos fitopatogenos no deseados. | |
| MX386501B (es) | Compuestos terapeuticos y sus metodos de uso |